Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.
The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.
Links to related guidelines are provided separately.
●(See "Society guideline links: Hirsutism".)
●(See "Society guideline links: Obesity in adults".)
●(See "Society guideline links: Classic and nonclassic congenital adrenal hyperplasia due to 21-hydroxylase deficiency".)
●(See "Society guideline links: Female infertility".)
International
●Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome (2023)
●Endocrine Society (ES): Clinical practice guideline for the evaluation and treatment of hirsutism in premenopausal women (2018)
●Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome (2018)
●International Consortium of Paediatric Endocrinology (ICPE): An international consortium update – Pathophysiology, diagnosis, and treatment of polycystic ovarian syndrome in adolescence (2017)
●American Association of Clinical Endocrinologists (AACE), American College of Endocrinology (ACE), and Androgen Excess and PCOS Society (AES): Disease state clinical review – Guide to the best practices in the evaluation and treatment of polycystic ovary syndrome: Part 1 (2015)
●AACE, ACE, and AES: Disease state clinical review – Guide to the best practices in the evaluation and treatment of polycystic ovary syndrome: Part 2 (2015)
●The diagnosis of polycystic ovary syndrome during adolescence (2015)
●AES: A task force report on definition and significance of polycystic ovarian morphology (2014)
●AES: A consensus statement for epidemiology, diagnosis and management of hirsutism (2012)
●AES: A consensus statement for the assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome (2010)
●AES: A position statement on the treatment of obesity in polycystic ovary syndrome (2009)
●AES: Criteria for the polycystic ovary syndrome – The complete task force report (2009)
●AES: A position statement on glucose intolerance in polycystic ovary syndrome (2007)
Canada
●Society of Obstetricians and Gynaecologists (SOGC): Clinical practice guideline – Hirsutism: Evaluation and treatment (2017)
●SOGC: Clinical practice guideline on ovulation induction in polycystic ovary syndrome (2010)
United States
●Amsterdam ESHRE/ASRM-sponsored 3rd PCOS Consensus Workshop Group: Consensus on women's health aspects of polycystic ovary syndrome (PCOS) (2012)
Europe
●Centre for Research Excellence in Polycystic Ovary Syndrome (CREPCOS), European Society of Human Reproduction and Embryology (ESHRE), and American Society of Reproductive Medicine (ASRM): International evidence-based guideline for the assessment and management of polycystic ovary syndrome (2018)
●European Society of Endocrinology (ESE): A position statement on the polycystic ovary syndrome (2014)
●Amsterdam ESHRE/ASRM-sponsored 3rd PCOS Consensus Workshop Group: Consensus on women's health aspects of polycystic ovary syndrome (PCOS) (2012)
United Kingdom
●National Institute for Health and Care Excellence (NICE): Clinical guideline on fertility problems – Assessment and treatment (2013, updated 2017)
●Royal College of Obstetricians and Gynaecologists (RCOG): Green-top guideline on long-term consequences of polycystic ovary syndrome (2014)
Australia
●Centre for Research Excellence in Polycystic Ovary Syndrome (CREPCOS), European Society of Human Reproduction and Embryology (ESHRE), and American Society of Reproductive Medicine (ASRM): International evidence-based guideline for the assessment and management of polycystic ovary syndrome (2018)
